Featured Post

Community-Acquired Pneumonia (CAP)

Image
pulmonary venous hypertension :: Article Creator Insmed Stock Soars On Pulmonary Arterial Hypertension Drug Trial Results Shares of Insmed (INSM) jumped nearly 30% Tuesday after the biopharmaceutical company reported positive results from a Phase 2 trial for its treatment of pulmonary arterial hypertension. The Bridgewater, N.J.-based company said the study was "evaluating the efficacy and safety of treprostinil palmitil inhalation powder" in patients with pulmonary arterial hypertension, or PAH, and that the trial "met its primary endpoint and all secondary efficacy endpoints." Pulmonary hypertension, which develops when the blood pressure in your lungs is higher than normal, affects about 1% of people globally, per the National Heart, Lung, and Blood Institute. Insmed said it would "immediately engage with the U.S. Food and Drug Administration (FDA) regarding the Phase 3 trial design for PAH. Insmed plans to in...

...Lifetime infection...' | News | lewistownnews.com - Lewistown News-Argus

Ramsey

A dog named Ramsey snuggles in a quilt. Dog owners, dog breeders and dog rescue groups are struggling with the rise in canine brucellosis in Montana.

While canine brucellosis (scientific name Brucella canis) has been known in the U.S. since 1966 and in Montana since 2015, a recent rise in the number of dogs testing positive for the disease has led the Montana Department of Livestock to issue warnings to dog breeders, dog owners and dog shelters.

Sadly, the disease has no cure, so the dire recommendation for infected dogs is usually euthanasia.

Comments

Popular Posts

Model Monday's: Diana Moldovan

“Teaching a pandemic in real time, part 2 . Princeton professors share how they incorporate the study - Princeton University” plus 1 more

Preventing, controlling spread of animal diseases focus of forum at Penn State - Pennsylvania State University